Methamphetamine Precursor Control Act of 2005

Bill: 109-hr-1056
Sponsor: Rep. Hooley, Darlene [D-OR-5]
Introduced: 2005-03-02 in the House
Policy area: Crime and Law Enforcement
Subjects: Business records
Chemicals
Commerce
Congress
Congressional reporting requirements
Data banks
Drug abuse
Drug industry
Drug law enforcement
Drug traffic
Drugs
Economics and Public Finance
Electronic government information
Federal aid to research
Foreign Trade and International Finance
Government Operations and Politics
Government paperwork
Government publicity
Health
Import restrictions
Imports
Internet
Larceny
Law
Licenses
Medical research
Methamphetamine
Oregon
Performance measurement
Pharmacies
Research grants
Retail trade
Science, Technology, Communications
State laws
Telephone
Web sites

Summary:
action_date: 2005-03-02
text: 
Methamphetamine Precursor Control Act of 2005 - Amends the Controlled Substances Import and Export Act to place limitations on the importation of ephedrine, pseudoephedrine, or phenylpropanolamine. Authorizes the Attorney General to: (1) request a distributor of a chemical in the chain of distribution to provide information on such distribution, including sales; and (2) issue an order, upon determining that a foreign-chain distributor is refusing to cooperate, prohibiting the importation of such substances.
 
Directs the Attorney General, acting through the Administrator of the Drug Enforcement Administration, to carry out a MethWatch program to provide information to retailers regarding the purchase of precursor products by individuals who may intend to use them in illicit methamphetamine production.
 
Amends the Controlled Substances Act to require the Attorney General to revoke the authority of a person whose registration includes authority regarding ephedrine, pseudoephedrine, or phenylpropanolamine, if such person has received four written notifications that the Attorney General considers the person to be in violation of the Act.
 
Requires a registration that includes authority for the sale of ephedrine or pseudoephedrine at retail to provide that the registration does not permit such a sale in which more than nine grams is sold in a single transaction. Prohibits knowingly or intentionally possessing more than 24 grams of pseudoephedrine unless specified conditions apply, such as the chemical is possessed for a legitimate medical purpose.
 
Authorizes additional funding to support research through the National Institutes of Health toward developing drug alternatives to pseudoephedrine.


Legislative actions:
action_date: 2005-04-04
text: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
action_date: 2005-03-14
text: Referred to the Subcommittee on Health.
action_date: 2005-03-02
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2005-03-02
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2005-03-02
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2005-03-02
text: Introduced in House
action_date: 2005-03-02
text: Introduced in House